| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 8.97e-05 | 115 | 16 | 3 | GO:0018107 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 9.37e-05 | 324 | 16 | 4 | GO:0006302 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.15e-04 | 125 | 16 | 3 | GO:0018210 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 3.82e-04 | 188 | 16 | 3 | GO:0000724 | |
| GeneOntologyBiologicalProcess | recombinational repair | 4.19e-04 | 194 | 16 | 3 | GO:0000725 | |
| GeneOntologyBiologicalProcess | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.77e-04 | 42 | 16 | 2 | GO:0032435 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 5.51e-04 | 213 | 16 | 3 | GO:0030307 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 5.67e-04 | 519 | 16 | 4 | GO:0001558 | |
| GeneOntologyBiologicalProcess | protein exit from endoplasmic reticulum | 7.04e-04 | 51 | 16 | 2 | GO:0032527 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 7.24e-04 | 234 | 16 | 3 | GO:0006282 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 7.75e-04 | 564 | 16 | 4 | GO:0051052 | |
| GeneOntologyBiologicalProcess | negative regulation of proteasomal protein catabolic process | 1.01e-03 | 61 | 16 | 2 | GO:1901799 | |
| GeneOntologyBiologicalProcess | negative regulation of ubiquitin-dependent protein catabolic process | 1.01e-03 | 61 | 16 | 2 | GO:2000059 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 1.05e-03 | 1081 | 16 | 5 | GO:0006259 | |
| GeneOntologyBiologicalProcess | cell growth | 1.14e-03 | 625 | 16 | 4 | GO:0016049 | |
| GeneOntologyBiologicalProcess | protein catabolic process | 1.21e-03 | 1115 | 16 | 5 | GO:0030163 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | 1.24e-03 | 640 | 16 | 4 | GO:0006511 | |
| GeneOntologyBiologicalProcess | DNA repair | 1.30e-03 | 648 | 16 | 4 | GO:0006281 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 1.32e-03 | 651 | 16 | 4 | GO:0019941 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 1.36e-03 | 656 | 16 | 4 | GO:0043632 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance | 1.40e-03 | 72 | 16 | 2 | GO:0032206 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.58e-03 | 307 | 16 | 3 | GO:0018105 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 1.68e-03 | 79 | 16 | 2 | GO:1905818 | |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis involved in protein catabolic process | 1.68e-03 | 79 | 16 | 2 | GO:1903051 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.77e-03 | 319 | 16 | 3 | GO:0018209 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 1.85e-03 | 83 | 16 | 2 | GO:0010569 | |
| GeneOntologyBiologicalProcess | growth | 1.91e-03 | 1235 | 16 | 5 | GO:0040007 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 2.06e-03 | 1256 | 16 | 5 | GO:0051726 | |
| GeneOntologyBiologicalProcess | chromosome separation | 2.08e-03 | 88 | 16 | 2 | GO:0051304 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 2.10e-03 | 339 | 16 | 3 | GO:0045927 | |
| GeneOntologyBiologicalProcess | regulation of growth | 2.53e-03 | 777 | 16 | 4 | GO:0040008 | |
| GeneOntologyBiologicalProcess | DNA recombination | 2.65e-03 | 368 | 16 | 3 | GO:0006310 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | 2.97e-03 | 812 | 16 | 4 | GO:0051603 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 3.34e-03 | 112 | 16 | 2 | GO:0032204 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome organization | 3.40e-03 | 113 | 16 | 2 | GO:2001252 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 3.43e-03 | 845 | 16 | 4 | GO:0010564 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | 3.53e-03 | 407 | 16 | 3 | GO:0042176 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 3.80e-03 | 418 | 16 | 3 | GO:0009895 | |
| GeneOntologyBiologicalProcess | negative regulation of protein catabolic process | 4.53e-03 | 131 | 16 | 2 | GO:0042177 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 5.09e-03 | 139 | 16 | 2 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.09e-03 | 139 | 16 | 2 | GO:0032434 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 5.12e-03 | 465 | 16 | 3 | GO:0007059 | |
| GeneOntologyBiologicalProcess | DNA damage response | 5.40e-03 | 959 | 16 | 4 | GO:0006974 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 5.60e-03 | 146 | 16 | 2 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 5.90e-03 | 150 | 16 | 2 | GO:0000018 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 1.47e-09 | 4 | 16 | 3 | GO:0005956 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.17e-04 | 157 | 16 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.74e-04 | 170 | 16 | 3 | GO:1902911 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.64e-04 | 1377 | 16 | 6 | GO:0140513 | |
| GeneOntologyCellularComponent | PcG protein complex | 7.12e-04 | 52 | 16 | 2 | GO:0031519 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.96e-03 | 335 | 16 | 3 | GO:0061695 | |
| GeneOntologyCellularComponent | nuclear body | 4.15e-03 | 903 | 16 | 4 | GO:0016604 | |
| GeneOntologyCellularComponent | transferase complex | 5.22e-03 | 963 | 16 | 4 | GO:1990234 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 5.40e-03 | 972 | 16 | 4 | GO:0140535 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.58e-02 | 254 | 16 | 2 | GO:0000228 | |
| Domain | Ser/Thr_kinase_AS | 3.22e-03 | 357 | 16 | 3 | IPR008271 | |
| Domain | S_TKc | 3.27e-03 | 359 | 16 | 3 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 3.35e-03 | 362 | 16 | 3 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 3.81e-03 | 379 | 16 | 3 | IPR017441 | |
| Domain | Pkinase | 3.87e-03 | 381 | 16 | 3 | PF00069 | |
| Domain | - | 6.12e-03 | 449 | 16 | 3 | 3.30.40.10 | |
| Domain | PROTEIN_KINASE_ATP | 6.51e-03 | 459 | 16 | 3 | PS00107 | |
| Domain | Znf_RING/FYVE/PHD | 6.51e-03 | 459 | 16 | 3 | IPR013083 | |
| Domain | Prot_kinase_dom | 7.75e-03 | 489 | 16 | 3 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 7.92e-03 | 493 | 16 | 3 | PS50011 | |
| Domain | Kinase-like_dom | 1.03e-02 | 542 | 16 | 3 | IPR011009 | |
| Domain | WD40 | 2.16e-02 | 268 | 16 | 2 | SM00320 | |
| Domain | WD40_repeat | 2.22e-02 | 272 | 16 | 2 | IPR001680 | |
| Domain | WD_REPEATS_1 | 2.31e-02 | 278 | 16 | 2 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.32e-02 | 279 | 16 | 2 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.32e-02 | 279 | 16 | 2 | PS50294 | |
| Domain | WD40_repeat_dom | 2.61e-02 | 297 | 16 | 2 | IPR017986 | |
| Pathway | KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.01e-07 | 13 | 11 | 3 | M47763 | |
| Pathway | KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I | 8.29e-06 | 6 | 11 | 2 | M47878 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 1.55e-05 | 8 | 11 | 2 | M27100 | |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 1.55e-05 | 8 | 11 | 2 | MM14895 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 1.99e-05 | 9 | 11 | 2 | MM14792 | |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 3.03e-05 | 11 | 11 | 2 | M27182 | |
| Pathway | REACTOME_RECEPTOR_MEDIATED_MITOPHAGY | 3.03e-05 | 11 | 11 | 2 | M27789 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2 | 3.64e-05 | 12 | 11 | 2 | M47943 | |
| Pathway | REACTOME_RECEPTOR_MEDIATED_MITOPHAGY | 3.64e-05 | 12 | 11 | 2 | MM15525 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 3.87e-05 | 89 | 11 | 3 | M39563 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 5.01e-05 | 14 | 11 | 2 | MM1531 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 5.16e-05 | 98 | 11 | 3 | M39731 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 6.60e-05 | 16 | 11 | 2 | M48235 | |
| Pathway | PID_DNA_PK_PATHWAY | 6.60e-05 | 16 | 11 | 2 | M42 | |
| Pathway | PID_NFKAPPAB_ATYPICAL_PATHWAY | 7.48e-05 | 17 | 11 | 2 | M26 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 7.90e-05 | 113 | 11 | 3 | M39669 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 9.40e-05 | 19 | 11 | 2 | MM15113 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.04e-04 | 20 | 11 | 2 | MM1389 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.15e-04 | 21 | 11 | 2 | M878 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 1.27e-04 | 22 | 11 | 2 | MM1409 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 1.27e-04 | 22 | 11 | 2 | MM1415 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 1.27e-04 | 22 | 11 | 2 | MM1440 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.37e-04 | 136 | 11 | 3 | M42547 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 1.39e-04 | 23 | 11 | 2 | MM1527 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.39e-04 | 23 | 11 | 2 | MM1411 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 1.51e-04 | 24 | 11 | 2 | MM1425 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.64e-04 | 25 | 11 | 2 | MM1519 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 1.78e-04 | 26 | 11 | 2 | MM14584 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.98e-04 | 154 | 11 | 3 | M39739 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 2.07e-04 | 28 | 11 | 2 | M684 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.07e-04 | 28 | 11 | 2 | MM1386 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.22e-04 | 29 | 11 | 2 | MM1452 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.06e-04 | 34 | 11 | 2 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.63e-04 | 37 | 11 | 2 | M27797 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 3.83e-04 | 38 | 11 | 2 | M27656 | |
| Pathway | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | 3.83e-04 | 38 | 11 | 2 | M229 | |
| Pathway | PID_ECADHERIN_NASCENT_AJ_PATHWAY | 4.04e-04 | 39 | 11 | 2 | M156 | |
| Pathway | REACTOME_MITOPHAGY | 4.04e-04 | 39 | 11 | 2 | M27418 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 4.04e-04 | 39 | 11 | 2 | MM15003 | |
| Pathway | REACTOME_MITOPHAGY | 4.46e-04 | 41 | 11 | 2 | MM15166 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 9.27e-04 | 261 | 11 | 3 | M42565 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.23e-03 | 68 | 11 | 2 | MM14968 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 1.26e-03 | 69 | 11 | 2 | MM15540 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 1.26e-03 | 69 | 11 | 2 | M27815 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.41e-03 | 73 | 11 | 2 | MM15672 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.41e-03 | 73 | 11 | 2 | M638 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.76e-03 | 326 | 11 | 3 | M39379 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.14e-03 | 90 | 11 | 2 | M29841 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 2.23e-03 | 92 | 11 | 2 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 2.23e-03 | 92 | 11 | 2 | M27636 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.53e-03 | 98 | 11 | 2 | M776 | |
| Pathway | REACTOME_PTEN_REGULATION | 2.53e-03 | 98 | 11 | 2 | MM15348 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 3.17e-03 | 110 | 11 | 2 | MM15977 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 3.76e-03 | 120 | 11 | 2 | MM14585 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.76e-03 | 120 | 11 | 2 | M48233 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.82e-03 | 121 | 11 | 2 | M872 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 4.07e-03 | 125 | 11 | 2 | M45021 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 4.11e-03 | 439 | 11 | 3 | M42563 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 4.26e-03 | 128 | 11 | 2 | M706 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 4.40e-03 | 130 | 11 | 2 | MM14627 | |
| Pathway | KEGG_TIGHT_JUNCTION | 4.53e-03 | 132 | 11 | 2 | M11355 | |
| Pathway | REACTOME_PTEN_REGULATION | 5.01e-03 | 139 | 11 | 2 | M27646 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 5.88e-03 | 151 | 11 | 2 | M19428 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 6.04e-03 | 153 | 11 | 2 | MM15522 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 6.35e-03 | 157 | 11 | 2 | MM15226 | |
| Pathway | REACTOME_AUTOPHAGY | 6.42e-03 | 158 | 11 | 2 | M27935 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 6.42e-03 | 158 | 11 | 2 | MM14791 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 6.58e-03 | 160 | 11 | 2 | M27498 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 9.74e-03 | 196 | 11 | 2 | MM14591 | |
| Pathway | REACTOME_CELL_CYCLE | 9.93e-03 | 603 | 11 | 3 | MM14635 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.03e-02 | 202 | 11 | 2 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.05e-02 | 204 | 11 | 2 | M4217 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 1.11e-02 | 210 | 11 | 2 | M41836 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 1.12e-02 | 211 | 11 | 2 | M649 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.36e-02 | 233 | 11 | 2 | M27099 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.40e-02 | 237 | 11 | 2 | M27786 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.42e-02 | 239 | 11 | 2 | MM14756 | |
| Pathway | REACTOME_CELL_CYCLE | 1.46e-02 | 694 | 11 | 3 | M543 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.57e-02 | 252 | 11 | 2 | MM15585 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.68e-02 | 261 | 11 | 2 | MM15676 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.91e-02 | 768 | 11 | 3 | MM14851 | |
| Pubmed | 9.70e-11 | 3 | 17 | 3 | 1766873 | ||
| Pubmed | 9.70e-11 | 3 | 17 | 3 | 2174700 | ||
| Pubmed | A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. | 3.39e-09 | 7 | 17 | 3 | 11239457 | |
| Pubmed | 5.42e-09 | 8 | 17 | 3 | 12393879 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 11704824 | ||
| Pubmed | CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. | 2.25e-07 | 2 | 17 | 2 | 26598688 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 7896000 | ||
| Pubmed | Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity. | 2.25e-07 | 2 | 17 | 2 | 33944995 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 11423974 | ||
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 2.25e-07 | 2 | 17 | 2 | 1577469 | |
| Pubmed | Molecular cloning of the human casein kinase II alpha subunit. | 2.25e-07 | 2 | 17 | 2 | 2752008 | |
| Pubmed | Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. | 2.25e-07 | 2 | 17 | 2 | 10471512 | |
| Pubmed | Structure and sequence of an intronless gene for human casein kinase II-alpha subunit. | 2.25e-07 | 2 | 17 | 2 | 8420794 | |
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 2.25e-07 | 2 | 17 | 2 | 12860116 | |
| Pubmed | Casein kinase 2 and microtubules control axon initial segment formation. | 2.25e-07 | 2 | 17 | 2 | 20850541 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21761202 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 1497660 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 10970045 | ||
| Pubmed | Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes. | 2.25e-07 | 2 | 17 | 2 | 12568341 | |
| Pubmed | Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. | 2.25e-07 | 2 | 17 | 2 | 21769451 | |
| Pubmed | Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function. | 2.25e-07 | 2 | 17 | 2 | 23290496 | |
| Pubmed | Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition. | 2.25e-07 | 2 | 17 | 2 | 29243286 | |
| Pubmed | Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection. | 2.25e-07 | 2 | 17 | 2 | 33363536 | |
| Pubmed | Structural basis of CX-4945 binding to human protein kinase CK2. | 2.25e-07 | 2 | 17 | 2 | 21093442 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 38503901 | ||
| Pubmed | Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners. | 2.25e-07 | 2 | 17 | 2 | 11827170 | |
| Pubmed | Subcellular localization of protein kinase CK2. A key to its function? | 2.25e-07 | 2 | 17 | 2 | 10994779 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 2.25e-07 | 2 | 17 | 2 | 14646071 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21739153 | ||
| Pubmed | Interaction between casein kinase II and the 90-kDa stress protein, HSP90. | 6.74e-07 | 3 | 17 | 2 | 7794926 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12102635 | ||
| Pubmed | Phosphorylation of the 105-kDa heat shock proteins, HSP105alpha and HSP105beta, by casein kinase II. | 6.74e-07 | 3 | 17 | 2 | 10772927 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10549869 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 2900140 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 1985907 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8206911 | ||
| Pubmed | A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. | 6.74e-07 | 3 | 17 | 2 | 21527517 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8548340 | ||
| Pubmed | Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation. | 6.74e-07 | 3 | 17 | 2 | 15684395 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8663258 | ||
| Pubmed | Phosphorylation of the Spi-B transcription factor reduces its intrinsic stability. | 6.74e-07 | 3 | 17 | 2 | 10618498 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25422081 | ||
| Pubmed | Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. | 6.74e-07 | 3 | 17 | 2 | 2557337 | |
| Pubmed | Phosphorylation by casein kinase 2 regulates Nap1 localization and function. | 6.74e-07 | 3 | 17 | 2 | 18086883 | |
| Pubmed | Identification of the phosphorylation sites of clathrin light chain LCb. | 6.74e-07 | 3 | 17 | 2 | 3128543 | |
| Pubmed | The role of protein kinase CK2 in the regulation of the insulin production of pancreatic islets. | 6.74e-07 | 3 | 17 | 2 | 20849816 | |
| Pubmed | Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells. | 6.74e-07 | 3 | 17 | 2 | 2998765 | |
| Pubmed | Characterization of protein interaction among subunits of protein kinase CKII in vivo and in vitro. | 6.74e-07 | 3 | 17 | 2 | 9571630 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18186541 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7491787 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9188720 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8107101 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8058322 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 31779225 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12860119 | ||
| Pubmed | Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis. | 6.74e-07 | 3 | 17 | 2 | 10066810 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10964683 | ||
| Pubmed | Crystallization and preliminary characterization of crystals of human protein kinase CK2. | 6.74e-07 | 3 | 17 | 2 | 11092945 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 28052864 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9930733 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8954982 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 1520270 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 2663470 | ||
| Pubmed | Phosphorylated syntaxin 1 is localized to discrete domains along a subset of axons. | 6.74e-07 | 3 | 17 | 2 | 10844023 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9881639 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7768894 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 19556345 | ||
| Pubmed | Casein kinase II phosphorylation increases the rate of serum response factor-binding site exchange. | 6.74e-07 | 3 | 17 | 2 | 1740119 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8622969 | ||
| Pubmed | NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells. | 6.74e-07 | 3 | 17 | 2 | 16581776 | |
| Pubmed | Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. | 6.74e-07 | 3 | 17 | 2 | 1516134 | |
| Pubmed | Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2'). | 6.74e-07 | 3 | 17 | 2 | 10984616 | |
| Pubmed | Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. | 6.74e-07 | 3 | 17 | 2 | 8663403 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8547318 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 2874131 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7651819 | ||
| Pubmed | Insulin regulates serine/threonine phosphorylation in activated human B lymphocytes. | 6.74e-07 | 3 | 17 | 2 | 7678037 | |
| Pubmed | Biochemical characterization of HIV-1 Rev as a potent activator of casein kinase II in vitro. | 6.74e-07 | 3 | 17 | 2 | 9654140 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7983041 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9074495 | ||
| Pubmed | Protein kinase CK2 phosphorylates Hsp105 alpha at Ser509 and modulates its function. | 6.74e-07 | 3 | 17 | 2 | 12558502 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 8288648 | ||
| Pubmed | Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. | 6.74e-07 | 3 | 17 | 2 | 1541298 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 28939766 | ||
| Pubmed | Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer. | 6.74e-07 | 3 | 17 | 2 | 20625391 | |
| Pubmed | Casein kinase II phosphorylates the neural cell adhesion molecule L1. | 6.74e-07 | 3 | 17 | 2 | 8592152 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11004567 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11827178 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11827177 | ||
| Pubmed | Protein kinase CK2: signaling and tumorigenesis in the mammary gland. | 6.74e-07 | 3 | 17 | 2 | 11827167 | |
| Pubmed | HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2. | 6.74e-07 | 3 | 17 | 2 | 11827166 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12564933 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15818404 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25788269 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 21383183 | ||
| Pubmed | Specific phosphorylation of the acidic central region of the N-myc protein by casein kinase II. | 6.74e-07 | 3 | 17 | 2 | 1425701 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10944435 | ||
| Pubmed | Identification of sites on chromosomal protein HMG-I phosphorylated by casein kinase II. | 6.74e-07 | 3 | 17 | 2 | 2806554 | |
| Pubmed | The carboxy-terminal domain of Grp94 binds to protein kinase CK2 alpha but not to CK2 holoenzyme. | 6.74e-07 | 3 | 17 | 2 | 11557039 | |
| Pubmed | Two putative protein kinase CK2 phosphorylation sites are important for Myf-5 activity. | 6.74e-07 | 3 | 17 | 2 | 9461343 | |
| Interaction | F2RL3 interactions | 4.17e-08 | 9 | 17 | 3 | int:F2RL3 | |
| Interaction | CT45A3 interactions | 4.17e-08 | 9 | 17 | 3 | int:CT45A3 | |
| Interaction | EFCAB14 interactions | 5.96e-08 | 10 | 17 | 3 | int:EFCAB14 | |
| Interaction | ANKRD36C interactions | 1.09e-07 | 12 | 17 | 3 | int:ANKRD36C | |
| Interaction | IPMK interactions | 1.42e-07 | 13 | 17 | 3 | int:IPMK | |
| Interaction | HAGHL interactions | 1.42e-07 | 13 | 17 | 3 | int:HAGHL | |
| Interaction | PCDH18 interactions | 2.77e-07 | 16 | 17 | 3 | int:PCDH18 | |
| Interaction | KLHL6 interactions | 9.98e-07 | 24 | 17 | 3 | int:KLHL6 | |
| Interaction | CT45A1 interactions | 1.28e-06 | 26 | 17 | 3 | int:CT45A1 | |
| Interaction | ANKRD36 interactions | 2.44e-06 | 32 | 17 | 3 | int:ANKRD36 | |
| Interaction | MBD3 interactions | 3.48e-06 | 295 | 17 | 5 | int:MBD3 | |
| Interaction | GPATCH2 interactions | 3.50e-06 | 36 | 17 | 3 | int:GPATCH2 | |
| Interaction | MMP1 interactions | 3.81e-06 | 37 | 17 | 3 | int:MMP1 | |
| Interaction | AUTS2 interactions | 4.83e-06 | 40 | 17 | 3 | int:AUTS2 | |
| Interaction | ABR interactions | 5.21e-06 | 41 | 17 | 3 | int:ABR | |
| Interaction | NOLC1 interactions | 5.58e-06 | 325 | 17 | 5 | int:NOLC1 | |
| Interaction | JADE2 interactions | 8.42e-06 | 48 | 17 | 3 | int:JADE2 | |
| Interaction | MAK16 interactions | 8.83e-06 | 162 | 17 | 4 | int:MAK16 | |
| Interaction | EIF6 interactions | 9.81e-06 | 365 | 17 | 5 | int:EIF6 | |
| Interaction | LYST interactions | 1.14e-05 | 53 | 17 | 3 | int:LYST | |
| Interaction | CFAP97 interactions | 1.42e-05 | 57 | 17 | 3 | int:CFAP97 | |
| Interaction | ANKRD36B interactions | 1.66e-05 | 60 | 17 | 3 | int:ANKRD36B | |
| Interaction | GPATCH2L interactions | 2.87e-05 | 72 | 17 | 3 | int:GPATCH2L | |
| Interaction | POLR1A interactions | 2.94e-05 | 220 | 17 | 4 | int:POLR1A | |
| Interaction | NUCKS1 interactions | 2.94e-05 | 220 | 17 | 4 | int:NUCKS1 | |
| Interaction | GRAMD1B interactions | 3.24e-05 | 75 | 17 | 3 | int:GRAMD1B | |
| Interaction | SNAPC4 interactions | 3.37e-05 | 76 | 17 | 3 | int:SNAPC4 | |
| Interaction | PPP1R1B interactions | 4.40e-05 | 12 | 17 | 2 | int:PPP1R1B | |
| Interaction | HIRIP3 interactions | 5.06e-05 | 87 | 17 | 3 | int:HIRIP3 | |
| Interaction | ZXDA interactions | 5.20e-05 | 13 | 17 | 2 | int:ZXDA | |
| Interaction | RPS6 interactions | 5.36e-05 | 874 | 17 | 6 | int:RPS6 | |
| Interaction | PES1 interactions | 5.48e-05 | 258 | 17 | 4 | int:PES1 | |
| Interaction | CREM interactions | 5.60e-05 | 90 | 17 | 3 | int:CREM | |
| Interaction | NKTR interactions | 5.60e-05 | 90 | 17 | 3 | int:NKTR | |
| Interaction | PCGF3 interactions | 5.60e-05 | 90 | 17 | 3 | int:PCGF3 | |
| Interaction | PIP4K2B interactions | 6.79e-05 | 96 | 17 | 3 | int:PIP4K2B | |
| Interaction | TTLL7 interactions | 6.99e-05 | 15 | 17 | 2 | int:TTLL7 | |
| Interaction | RNF111 interactions | 7.00e-05 | 97 | 17 | 3 | int:RNF111 | |
| Interaction | NEIL1 interactions | 7.12e-05 | 276 | 17 | 4 | int:NEIL1 | |
| Interaction | EIF3CL interactions | 7.22e-05 | 98 | 17 | 3 | int:EIF3CL | |
| Interaction | DGKZ interactions | 7.44e-05 | 99 | 17 | 3 | int:DGKZ | |
| Interaction | AKAP17A interactions | 7.44e-05 | 99 | 17 | 3 | int:AKAP17A | |
| Interaction | PCGF5 interactions | 7.89e-05 | 101 | 17 | 3 | int:PCGF5 | |
| Interaction | VSX2 interactions | 7.98e-05 | 16 | 17 | 2 | int:VSX2 | |
| Interaction | FBRS interactions | 8.13e-05 | 102 | 17 | 3 | int:FBRS | |
| Interaction | GTF2A1 interactions | 8.61e-05 | 104 | 17 | 3 | int:GTF2A1 | |
| Interaction | SAP30BP interactions | 8.86e-05 | 105 | 17 | 3 | int:SAP30BP | |
| Interaction | EIF3F interactions | 9.33e-05 | 296 | 17 | 4 | int:EIF3F | |
| Interaction | RSRC1 interactions | 1.07e-04 | 112 | 17 | 3 | int:RSRC1 | |
| Interaction | GRAMD1C interactions | 1.14e-04 | 19 | 17 | 2 | int:GRAMD1C | |
| Interaction | ZNF687 interactions | 1.16e-04 | 115 | 17 | 3 | int:ZNF687 | |
| Interaction | ARK2N interactions | 1.19e-04 | 116 | 17 | 3 | int:ARK2N | |
| Interaction | SPIB interactions | 1.26e-04 | 20 | 17 | 2 | int:SPIB | |
| Interaction | MEN1 interactions | 1.33e-04 | 1029 | 17 | 6 | int:MEN1 | |
| Interaction | BHLHE23 interactions | 1.39e-04 | 21 | 17 | 2 | int:BHLHE23 | |
| Interaction | EIF3J interactions | 1.67e-04 | 130 | 17 | 3 | int:EIF3J | |
| Interaction | NKAP interactions | 1.75e-04 | 132 | 17 | 3 | int:NKAP | |
| Interaction | ZNF670 interactions | 1.83e-04 | 24 | 17 | 2 | int:ZNF670 | |
| Interaction | H2AB3 interactions | 1.91e-04 | 136 | 17 | 3 | int:H2AB3 | |
| Interaction | AQP4 interactions | 1.99e-04 | 25 | 17 | 2 | int:AQP4 | |
| Interaction | IFI16 interactions | 2.39e-04 | 714 | 17 | 5 | int:IFI16 | |
| Interaction | ZC3H4 interactions | 2.40e-04 | 147 | 17 | 3 | int:ZC3H4 | |
| Interaction | PARN interactions | 2.45e-04 | 148 | 17 | 3 | int:PARN | |
| Interaction | CCDC82 interactions | 2.50e-04 | 28 | 17 | 2 | int:CCDC82 | |
| Interaction | RTF1 interactions | 2.55e-04 | 150 | 17 | 3 | int:RTF1 | |
| Interaction | POLR3B interactions | 2.65e-04 | 152 | 17 | 3 | int:POLR3B | |
| Interaction | MTPN interactions | 2.97e-04 | 158 | 17 | 3 | int:MTPN | |
| Interaction | PIP4K2C interactions | 3.02e-04 | 159 | 17 | 3 | int:PIP4K2C | |
| Interaction | TFPT interactions | 3.08e-04 | 160 | 17 | 3 | int:TFPT | |
| Interaction | NKAPD1 interactions | 3.13e-04 | 161 | 17 | 3 | int:NKAPD1 | |
| Interaction | WDR12 interactions | 3.19e-04 | 162 | 17 | 3 | int:WDR12 | |
| Interaction | GTF2A1L interactions | 3.27e-04 | 32 | 17 | 2 | int:GTF2A1L | |
| Interaction | MAF1 interactions | 3.27e-04 | 32 | 17 | 2 | int:MAF1 | |
| Interaction | DDX41 interactions | 3.43e-04 | 166 | 17 | 3 | int:DDX41 | |
| Interaction | GRIN2B interactions | 3.68e-04 | 170 | 17 | 3 | int:GRIN2B | |
| Interaction | DELEC1 interactions | 3.70e-04 | 34 | 17 | 2 | int:DELEC1 | |
| Interaction | EIF3K interactions | 3.74e-04 | 171 | 17 | 3 | int:EIF3K | |
| Interaction | BRD2 interactions | 3.87e-04 | 429 | 17 | 4 | int:BRD2 | |
| Interaction | XRCC1 interactions | 3.87e-04 | 173 | 17 | 3 | int:XRCC1 | |
| Interaction | WDR46 interactions | 3.87e-04 | 173 | 17 | 3 | int:WDR46 | |
| Interaction | NIFK interactions | 3.94e-04 | 431 | 17 | 4 | int:NIFK | |
| Interaction | NUP133 interactions | 4.00e-04 | 175 | 17 | 3 | int:NUP133 | |
| Interaction | MTA2 interactions | 4.08e-04 | 435 | 17 | 4 | int:MTA2 | |
| Interaction | WDR48 interactions | 4.14e-04 | 177 | 17 | 3 | int:WDR48 | |
| Interaction | EIF2B5 interactions | 4.21e-04 | 178 | 17 | 3 | int:EIF2B5 | |
| Interaction | EIF4G2 interactions | 4.28e-04 | 179 | 17 | 3 | int:EIF4G2 | |
| Interaction | HLX interactions | 4.38e-04 | 37 | 17 | 2 | int:HLX | |
| Interaction | KLF1 interactions | 4.38e-04 | 37 | 17 | 2 | int:KLF1 | |
| Interaction | RGS19 interactions | 4.38e-04 | 37 | 17 | 2 | int:RGS19 | |
| Interaction | MYF5 interactions | 4.38e-04 | 37 | 17 | 2 | int:MYF5 | |
| Interaction | EIF3M interactions | 4.49e-04 | 182 | 17 | 3 | int:EIF3M | |
| Interaction | MECP2 interactions | 4.50e-04 | 1287 | 17 | 6 | int:MECP2 | |
| Interaction | ZSCAN5A interactions | 4.62e-04 | 38 | 17 | 2 | int:ZSCAN5A | |
| Interaction | SRPK3 interactions | 5.09e-04 | 190 | 17 | 3 | int:SRPK3 | |
| Interaction | BHLHE41 interactions | 5.13e-04 | 40 | 17 | 2 | int:BHLHE41 | |
| Interaction | PPAN interactions | 5.33e-04 | 193 | 17 | 3 | int:PPAN | |
| Interaction | ANKS3 interactions | 5.39e-04 | 41 | 17 | 2 | int:ANKS3 | |
| Interaction | HDGFL2 interactions | 5.41e-04 | 194 | 17 | 3 | int:HDGFL2 | |
| Interaction | SCARB2 interactions | 5.49e-04 | 195 | 17 | 3 | int:SCARB2 | |
| Interaction | YAF2 interactions | 5.65e-04 | 197 | 17 | 3 | int:YAF2 | |
| Cytoband | 20p13 | 6.50e-04 | 102 | 17 | 2 | 20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 9.43e-04 | 123 | 17 | 2 | chr20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.05e-02 | 423 | 17 | 2 | chr12q13 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 5.35e-05 | 115 | 17 | 3 | M7995 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.28e-04 | 26 | 17 | 2 | M1380 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 1.67e-04 | 1394 | 17 | 6 | M9585 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP | 1.76e-04 | 172 | 17 | 3 | M2951 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 1.83e-04 | 174 | 17 | 3 | M6296 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 2.67e-04 | 198 | 17 | 3 | M8440 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN | 2.71e-04 | 199 | 17 | 3 | M3917 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | 2.71e-04 | 199 | 17 | 3 | M8770 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 2.71e-04 | 199 | 17 | 3 | M316 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-5|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.30e-06 | 101 | 17 | 3 | f4db710b2510cdbee26dd5c3b581c85fe6f0be00 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.06e-05 | 193 | 17 | 3 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.13e-05 | 194 | 17 | 3 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-05 | 195 | 17 | 3 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| Drug | allyl phosphate | 5.25e-07 | 2 | 17 | 2 | CID000015390 | |
| Drug | 1-ethyl-4-carbamoyl-5-methylcarbamoylimidazole | 1.57e-06 | 3 | 17 | 2 | CID000130883 | |
| Drug | CP44 | 3.15e-06 | 4 | 17 | 2 | CID000452111 | |
| Drug | B501 | 3.15e-06 | 4 | 17 | 2 | CID000054108 | |
| Drug | NSC-122818 | 5.24e-06 | 5 | 17 | 2 | CID000275783 | |
| Drug | australifungin | 5.24e-06 | 5 | 17 | 2 | CID005276375 | |
| Drug | I Qa | 1.10e-05 | 7 | 17 | 2 | CID000447682 | |
| Drug | AC1O5LBH | 1.47e-05 | 8 | 17 | 2 | CID006436254 | |
| Drug | integric acid | 1.47e-05 | 8 | 17 | 2 | CID006475378 | |
| Drug | IdB 1031 | 1.88e-05 | 9 | 17 | 2 | CID000125309 | |
| Drug | 3'-hydroxydaidzein | 1.88e-05 | 9 | 17 | 2 | CID005284648 | |
| Drug | RPR103611 | 1.88e-05 | 9 | 17 | 2 | CID000072411 | |
| Drug | di-t-butylphosphite | 2.35e-05 | 10 | 17 | 2 | CID000518693 | |
| Drug | 2-amino-5-(N-ethylcarboxyamido)-pentanoic acid | 2.35e-05 | 10 | 17 | 2 | CID000194789 | |
| Drug | Asptpsa | 2.35e-05 | 10 | 17 | 2 | CID000132853 | |
| Drug | CKI-8 | 2.35e-05 | 10 | 17 | 2 | CID000486026 | |
| Drug | 8-chloro-3',4',5,7-tetrahydroxyisoflavone | 2.35e-05 | 10 | 17 | 2 | CID005486848 | |
| Drug | 5-chloroisoquinoline | 4.07e-05 | 13 | 17 | 2 | CID000224933 | |
| Drug | AC1L4M5O | 4.07e-05 | 13 | 17 | 2 | CID000159625 | |
| Drug | F-6b | 6.26e-05 | 16 | 17 | 2 | CID000004288 | |
| Drug | AC1L1GHZ | 9.89e-05 | 20 | 17 | 2 | CID000003691 | |
| Drug | NHS-LC-biotin | 1.32e-04 | 23 | 17 | 2 | CID000083874 | |
| Drug | EM2487 | 1.32e-04 | 23 | 17 | 2 | CID000475358 | |
| Drug | N-vinyl-2-pyrrolidinone | 1.69e-04 | 26 | 17 | 2 | ctd:C042670 | |
| Drug | AC1NPJQV | 1.69e-04 | 26 | 17 | 2 | CID005180209 | |
| Drug | S-ethylcysteine | 1.96e-04 | 28 | 17 | 2 | CID000030993 | |
| Drug | tri-n-butylborane | 1.96e-04 | 28 | 17 | 2 | CID000031216 | |
| Drug | diisopropylphosphate | 2.25e-04 | 30 | 17 | 2 | CID000074162 | |
| Drug | AC1L9M3Z | 3.63e-04 | 38 | 17 | 2 | CID000448575 | |
| Drug | 2-Br | 3.83e-04 | 39 | 17 | 2 | CID000007244 | |
| Drug | 3-deazacytidine | 4.52e-04 | 206 | 17 | 3 | CID000001652 | |
| Drug | 2-(2-naphthyloxy)propanoic acid | 5.56e-04 | 47 | 17 | 2 | CID000092236 | |
| Drug | Pp55 | 6.29e-04 | 50 | 17 | 2 | CID000132900 | |
| Drug | CKI-7 | 7.07e-04 | 53 | 17 | 2 | CID000129236 | |
| Drug | oxalylglycine | 7.34e-04 | 54 | 17 | 2 | CID003080614 | |
| Drug | O-Ir | 8.17e-04 | 57 | 17 | 2 | CID000448249 | |
| Drug | methylglyoxal bis(guanylhydrazone | 9.36e-04 | 61 | 17 | 2 | CID000009991 | |
| Drug | AC1O4DJ6 | 1.16e-03 | 68 | 17 | 2 | CID006386496 | |
| Drug | dl-Lysine | 1.22e-03 | 290 | 17 | 3 | CID000000866 | |
| Drug | K00051 | 1.27e-03 | 71 | 17 | 2 | CID009549278 | |
| Drug | DBTC | 1.34e-03 | 73 | 17 | 2 | CID000101938 | |
| Drug | NSC734102 | 1.37e-03 | 74 | 17 | 2 | CID000444075 | |
| Drug | dinitrogen | 1.64e-03 | 81 | 17 | 2 | CID000000947 | |
| Drug | 18b-glycyrrhetic acid | 1.72e-03 | 83 | 17 | 2 | CID000003230 | |
| Drug | cilostazol | 1.85e-03 | 86 | 17 | 2 | CID000002754 | |
| Drug | glycrrhizin | 1.85e-03 | 86 | 17 | 2 | CID000003495 | |
| Drug | CK2 inhibitor | 1.89e-03 | 87 | 17 | 2 | CID000001694 | |
| Disease | sleep latency | 1.82e-04 | 37 | 16 | 2 | EFO_0005280 | |
| Disease | Malignant neoplasm of skin | 4.63e-04 | 59 | 16 | 2 | C0007114 | |
| Disease | Skin Neoplasms | 4.63e-04 | 59 | 16 | 2 | C0037286 | |
| Disease | pursuit maintenance gain measurement | 1.99e-03 | 123 | 16 | 2 | EFO_0008433 | |
| Disease | Squamous cell carcinoma | 2.02e-03 | 124 | 16 | 2 | C0007137 | |
| Disease | serum IgG glycosylation measurement | 2.61e-03 | 523 | 16 | 3 | EFO_0005193 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.34e-03 | 160 | 16 | 2 | DOID:5844 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | 5.69e-03 | 1392 | 16 | 4 | EFO_0005763 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.31e-03 | 222 | 16 | 2 | EFO_0008317, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.81e-03 | 264 | 16 | 2 | EFO_0008317, EFO_0020944 | |
| Disease | late-onset Alzheimers disease | 1.07e-02 | 292 | 16 | 2 | EFO_1001870 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 1.52e-02 | 352 | 16 | 2 | EFO_0007014 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKRKLKKKQQIKRKK | 161 | Q86X53 | |
| PENLKKRKKRKKLKK | 276 | A2A2Z9 | |
| IRVIKKKKVIMKKRK | 66 | Q96SM3 | |
| MKVLKKKIKRVKKKE | 1486 | Q96MT7 | |
| KKLKAKLKKVKKKRR | 216 | Q9ULG1 | |
| RVKKMRTPKKKKIKL | 1426 | Q9UGL1 | |
| VVKILKPVKKKKIKR | 66 | Q8NEV1 | |
| KPVKKKKIKREIKIL | 71 | Q8NEV1 | |
| KKVKKRIQLSPKKIK | 241 | Q96P44 | |
| VVVKILKPVKKKKIK | 66 | P19784 | |
| LKPVKKKKIKREVKI | 71 | P19784 | |
| VVKILKPVKKKKIKR | 66 | P68400 | |
| KPVKKKKIKREIKIL | 71 | P68400 | |
| VIILPKKHKKKKERK | 6 | O60832 | |
| IIKKKKHFKKKRIKT | 1031 | Q03701 | |
| ELVKKHKKKRVVPKK | 511 | Q13438 | |
| QEPKLVKPKKKRRKK | 341 | Q70EK9 | |
| LKKVASRLKKKRKKK | 1171 | P53804 | |
| LRKAKKPKKKTKKRR | 776 | Q6NWY9 | |
| LVVKPIKVKRKKKKK | 456 | O15040 |